One in four adults suffer from hypertension (HTN) worldwide. Overactive sympathetic nervous system plays a vital role in pathogenesis of HTN. RENAL SYMPATHETIC DENERVATION (RDN) is a new minimally invasive catheter based treatment that has demonstrated exceptional blood pressure reductions in patient with resistant HTN. While RDN is being explored for its role in treatment of different clinical conditions worldwide, this platform provides comprehensive knowledge, news, education, and information on this innovative treatment with the goal of fast dissipation of RDN science.
For more information visit www.renaldenervationworld.org/